课题基金 / 基金详情

The role of mitochondrial DNA mutations and inflammation in adult blindness caused by diabetic retinopathy

The role of mitochondrial DNA mutations and inflammation in adult blindness caused by diabetic retinopathy
线粒体DNA突变和炎症在糖尿病视网膜病变引起的成人失明中的作用
批准号:
2072399
负责人:
金额:
$0.0万
依托单位:
依托单位国家:
英国
项目类别:
Studentship
财政年份:
2018
资助国家:
英国
项目状态:
未结题
起止时间:
2018 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Diabetic retinopathy (DR) is a major cause of blindness in the working-age population for which there is no treatment. Mitochondria are cellular organelles and the site of energy production in the cell. Mitochondrial dysfunction is involved in the development of DR, we recently published the first human study showing that MtDNA changes can be detected in blood samples from DR patients and have found, using patient blood samples and animal/cell models, that diabetes can lead to elevated circulating MtDNA. As MtDNA resembles bacterial DNA it may elicit an inflammatory response via activation of the TLR9 pathway and activate inflammasomes. Recently we have discovered novel MtDNA mutations and deletions in DR patients. In the current project the student will (a) test the hypothesis that damaged MtDNA is causative of energy deficit in the retina and chronic inflammation in circulation (b) characterise the time course of mitochondrial changes associated with DR using in-vitro models and (c) Identify and test therapeutic and preventative strategies. For the rotation/year 1, the student will use human patient samples to define the incidence of MtDNA mutations in DR. These studies will be expanded further and ARPE 19 cells will be used to mimic the damage seen in the retina in hyperglycemic conditions in order to characterise the mitochondrial changes and then test a range of therapeutic strategies. The student will gain training in a range of cell biology and molecular biology techniques including tissue culture, DNA/RNA work, real time quantitative PCR, functional assays and bioenergetics.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
糖尿病ED中成纤维细胞衰老调控内皮细胞线粒体稳态失衡的机制研究
  • 批准号:
    82371634
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    赵福军
  • 依托单位:
Idh3a作为线粒体代谢—表观遗传检查点调控产热脂肪功能的机制研究
  • 批准号:
    82370851
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    包玉倩
  • 依托单位:
胆固醇合成蛋白CYP51介导线粒体通透性转换诱发Th17/Treg细胞稳态失衡在舍格伦综合征中的作用机制研究
  • 批准号:
    82370976
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    郑凌艳
  • 依托单位:
损伤线粒体传递机制介导成纤维细胞/II型肺泡上皮细胞对话在支气管肺发育不良肺泡发育阻滞中的作用
  • 批准号:
    82371721
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    王星云
  • 依托单位: